Morningstar

Lonza Group Ltd LONN

Morningstar Rating
Unlock
Stock XSWX Rating as of
CHF 532.40 +1.00 (0.19%)
View Full Chart
As of Delayed Price Post-Trading: CHF 532.40 0.00

Company Report

View Archive

Price vs Fair Value

View History
LONN is trading at a 890% premium.
Price
CHF 531.40
Fair Value
CHF 442.00
Uncertainty
Medium
1-Star Price
CHF 157.70
5-Star Price
CHF 849.00
Economic Moat
Ngjtg
Capital Allocation
Dwbyvyg

Bulls Say, Bears Say

Bulls

The pharma biotech and nutrition segment is a sticky business with long-term contracts and high switching costs for its customers.

Bears

Lonza is vulnerable to facility closures whether from natural disasters or manufacturing issues, as a warning letter from the FDA can result in manufacturing delays or closures.

Show More

News

View All

Trading Information

Previous Close Price
CHF 531.40
Day Range
CHF 525.20–535.00
52-Week Range
CHF 308.60–589.40
Bid/Ask
CHF 530.00 / CHF 538.00
Market Cap
CHF 38.39 Bil
Volume/Avg
105,756 / 154,398

Key Statistics

Price/Earnings (Normalized)
32.98
Price/Sales
5.74
Dividend Yield (Trailing)
0.75%
Dividend Yield (Forward)
0.75%
Total Yield
3.81%

Company Profile

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Growth
Total Number of Employees
17,834
Website
https://www.lonza.com

Competitors

Valuation

View More
Metric
LONN
02269
CTLT
Price/Earnings (Normalized)
 32.9825.99241.76
Price/Book Value
 4.102.053.04
Price/Sales
 5.744.662.50
Price/Cash Flow
 28.8726.4833.16
Price/Earnings
LONN
02269
CTLT

Financial Strength

Metric
LONN
02269
CTLT
Quick Ratio
 1.382.401.56
Current Ratio
 2.042.912.51
Interest Coverage
 6.8823.45−4.07
Quick Ratio
LONN
02269
CTLT

Profitability

Metric
LONN
02269
CTLT
Return on Assets (Normalized)
 5.18%7.48%0.39%
Return on Equity (Normalized)
 9.32%11.09%1.01%
Return on Invested Capital (Normalized)
 7.38%8.36%2.72%
Return on Assets
LONN
02269
CTLT

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
JsxcnzqjSjf$234.1 Bil
 Danaher Corp
DHR
XdkltkwqVvzqx$197.8 Bil
 IQVIA Holdings Inc
IQV
QqblrtnjrFdpcvm$42.2 Bil
 Agilent Technologies Inc
A
QfzgczgkzfSntxn$42.1 Bil
 IDEXX Laboratories Inc
IDXX
SmqqqcktKrsbn$40.0 Bil
 Mettler-Toledo International Inc
MTD
XpvwfxrlwZpcxsn$31.8 Bil
 Icon PLC
ICLR
PcylcykpMscpd$24.4 Bil
 Illumina Inc
ILMN
CstshlmzvHmfzwn$22.1 Bil
 Waters Corp
WAT
DjrtzfdjBydx$21.1 Bil
 Labcorp Holdings Inc
LH
RgghhfxfhPqfmfg$18.4 Bil

Sponsor Center